Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

responsive web design (RWD)

- PMLiVE

The patient journey: A long and winding road

Reflections of a research executive

Porterhouse Medical Group

- PMLiVE

US secures 650,000 additional doses of Lilly’s COVID-19 antibody

This takes the total purchased amount to 950,000 doses

- PMLiVE

WHO set to review Pfizer/BioNTech COVID-19 vaccine for emergency use listing

Follows approval for emergency use in the UK yesterday

- PMLiVE

Sanofi Genzyme takes home New Product Introductions Award at PMEA 2020

Winning entry stood out in a strong category

- PMLiVE

Launch leaders’ blog part 3

How can launch leaders innovate?

- PMLiVE

EMA launches rolling review of J&J’s COVID-19 vaccine

Vaccine entered phase 3 testing in September

- PMLiVE

Novavax moves closer toward launch of US phase 3 COVID-19 vaccine trial

Company also completes enrolment in UK-based phase 3 trial

- PMLiVE

NHS set to pilot GRAIL’s wide-ranging cancer blood test

Previous study indicates test can detect over 50 cancer types

- PMLiVE

Pfizer/BioNTech’s COVID-19 vaccine gets first approval from UK

The UK has already signed a supply deal for 40 million doses

- PMLiVE

Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?

Providers are looking at digital solutions to transform this area of healthcare

- PMLiVE

AZ divests European rights for cholesterol med Crestor to Grünenthal

Grünenthal will pay up to $350m for the rights

- PMLiVE

Joint COVID-19 trial begins testing drugs from Amgen, UCB and Takeda

Trial will test therapeutic candidates in hospitalised COVID-19 patients

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links